Tesamorelin (10mg)

Tesamorelin (10mg): Product Description

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone, commonly abbreviated as GHRH. Its sequence includes a trans‑3‑hexenoic acid modification at the N-terminus, designed to alter stability while maintaining activity associated with the GHRH receptor in experimental systems.

Controlled laboratory studies involving Tesamorelin may examine GHRH-receptor binding, pituitary-cell signaling, cyclic AMP production and downstream pathways associated with growth hormone and IGF‑1 signaling. Researchers may also compare its molecular stability and receptor activity with naturally occurring GHRH under defined assay conditions.

Tesamorelin is a comparatively large research peptide, and reported molecular characteristics may vary depending on whether the free peptide, acetate salt, counterions or other formulation components are included. Its identity, purity and precise chemical form should therefore be verified through the batch Certificate of Analysis.

The 10 mg product supplied is designated exclusively for in-vitro research and is listed at a purity of at least 99% by HPLC. Descriptions of endocrine pathways are provided only to identify experimental research areas.

Research Specifications

Molecular Formula: C221H366N72O67S

Molecular Weight: Approximately 5,135.9 g/mol

CAS Number: 218949-48-5

Amino Acid Count: 44

Compound Type: Synthetic GHRH analog

Presentation: 10 mg

Research Target: GHRH-receptor signaling

Purity: ≥99% by HPLC

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.